Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia: No country for old men?

Nature Clinical Practice Oncology

Volumn 6, Issue 3, 2009, Pages 130-131

  Hamblin, Terry J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN KINASE ZAP 70; RITUXIMAB;

CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CYTOPENIA; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; GENE EXPRESSION; GENE MUTATION; HUMAN; LEUKEMIA REMISSION; MULTIPLE CYCLE TREATMENT; NOTE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 61849135406     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc1318     Document Type: Note

References (9)

1. Dighiero G and Hamblin TJ (2008) Chronic lymphocytic leukemia. Lancet 371: 1017-1029
2. Catovsky D et al. (2007) Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukemia (the LRF CLL4 trial): A randomised controlled trial. Lancet 370: 230-239
3. Hallek M et al. (2008) Immunochemotherapy with fludarabine (F), cyclophosphamide (C), and rituximab (R) (FCR) versus fludarabine and cyclophosphamide (FC) improves response rates and progression-free survival (PFS) of previously untreated patients (pts) with advanced chronic lymphocytic leukemia (CLL) [abstract]. Blood 112: a125
4. Milligan DW et al. (2005) Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. Blood 105: 397-404
5. Hamblin AD and Hamblin TJ (2008) The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull 87: 49-62
6. Tam CS et al. (2008) Long term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. Blood 112: 975-980
7. O'Brien S et al. (2001) Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol 19: 1414-1420
8. Keating M et al. (1998) Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 92: 1165-1171
9. Cheson BD et al. (1996) National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 87: 4990-4997